Global Inhaled Nitric Oxide Market Growth 2025-2031

March 2025 | 85 pages | ID: G6AA3111C98EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Inhaled Nitric Oxide market size is predicted to grow from US$ 1335 million in 2025 to US$ 2191 million in 2031; it is expected to grow at a CAGR of 8.6% from 2025 to 2031.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

LP Information, Inc. (LPI) ' newest research report, the “Inhaled Nitric Oxide Industry Forecast” looks at past sales and reviews total world Inhaled Nitric Oxide sales in 2024, providing a comprehensive analysis by region and market sector of projected Inhaled Nitric Oxide sales for 2025 through 2031. With Inhaled Nitric Oxide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhaled Nitric Oxide industry.

This Insight Report provides a comprehensive analysis of the global Inhaled Nitric Oxide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhaled Nitric Oxide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhaled Nitric Oxide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhaled Nitric Oxide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhaled Nitric Oxide.

This report presents a comprehensive overview, market shares, and growth opportunities of Inhaled Nitric Oxide market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 800 ppm
  • 100 ppm
  • Others
Segmentation by Application:
  • Near-term and Pre-term Infants PPHN
  • Children and Adult ARDS
  • Other Diseases
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Mallinckrodt
  • Praxair (Linde plc)
  • Air Liquide
  • BOC Healthcare (Linde Group)
Key Questions Addressed in this Report

What is the 10-year outlook for the global Inhaled Nitric Oxide market?

What factors are driving Inhaled Nitric Oxide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Inhaled Nitric Oxide market opportunities vary by end market size?

How does Inhaled Nitric Oxide break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Inhaled Nitric Oxide Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Inhaled Nitric Oxide by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Inhaled Nitric Oxide by Country/Region, 2020, 2024 & 2031
2.2 Inhaled Nitric Oxide Segment by Type
  2.2.1 800 ppm
  2.2.2 100 ppm
  2.2.3 Others
2.3 Inhaled Nitric Oxide Sales by Type
  2.3.1 Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
  2.3.2 Global Inhaled Nitric Oxide Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Inhaled Nitric Oxide Sale Price by Type (2020-2025)
2.4 Inhaled Nitric Oxide Segment by Application
  2.4.1 Near-term and Pre-term Infants PPHN
  2.4.2 Children and Adult ARDS
  2.4.3 Other Diseases
2.5 Inhaled Nitric Oxide Sales by Application
  2.5.1 Global Inhaled Nitric Oxide Sale Market Share by Application (2020-2025)
  2.5.2 Global Inhaled Nitric Oxide Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Inhaled Nitric Oxide Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Inhaled Nitric Oxide Breakdown Data by Company
  3.1.1 Global Inhaled Nitric Oxide Annual Sales by Company (2020-2025)
  3.1.2 Global Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
3.2 Global Inhaled Nitric Oxide Annual Revenue by Company (2020-2025)
  3.2.1 Global Inhaled Nitric Oxide Revenue by Company (2020-2025)
  3.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
3.3 Global Inhaled Nitric Oxide Sale Price by Company
3.4 Key Manufacturers Inhaled Nitric Oxide Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Inhaled Nitric Oxide Product Location Distribution
  3.4.2 Players Inhaled Nitric Oxide Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INHALED NITRIC OXIDE BY GEOGRAPHIC REGION

4.1 World Historic Inhaled Nitric Oxide Market Size by Geographic Region (2020-2025)
  4.1.1 Global Inhaled Nitric Oxide Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Inhaled Nitric Oxide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Inhaled Nitric Oxide Market Size by Country/Region (2020-2025)
  4.2.1 Global Inhaled Nitric Oxide Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Inhaled Nitric Oxide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Inhaled Nitric Oxide Sales Growth
4.4 APAC Inhaled Nitric Oxide Sales Growth
4.5 Europe Inhaled Nitric Oxide Sales Growth
4.6 Middle East & Africa Inhaled Nitric Oxide Sales Growth

5 AMERICAS

5.1 Americas Inhaled Nitric Oxide Sales by Country
  5.1.1 Americas Inhaled Nitric Oxide Sales by Country (2020-2025)
  5.1.2 Americas Inhaled Nitric Oxide Revenue by Country (2020-2025)
5.2 Americas Inhaled Nitric Oxide Sales by Type (2020-2025)
5.3 Americas Inhaled Nitric Oxide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Inhaled Nitric Oxide Sales by Region
  6.1.1 APAC Inhaled Nitric Oxide Sales by Region (2020-2025)
  6.1.2 APAC Inhaled Nitric Oxide Revenue by Region (2020-2025)
6.2 APAC Inhaled Nitric Oxide Sales by Type (2020-2025)
6.3 APAC Inhaled Nitric Oxide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Inhaled Nitric Oxide by Country
  7.1.1 Europe Inhaled Nitric Oxide Sales by Country (2020-2025)
  7.1.2 Europe Inhaled Nitric Oxide Revenue by Country (2020-2025)
7.2 Europe Inhaled Nitric Oxide Sales by Type (2020-2025)
7.3 Europe Inhaled Nitric Oxide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Inhaled Nitric Oxide by Country
  8.1.1 Middle East & Africa Inhaled Nitric Oxide Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Inhaled Nitric Oxide Revenue by Country (2020-2025)
8.2 Middle East & Africa Inhaled Nitric Oxide Sales by Type (2020-2025)
8.3 Middle East & Africa Inhaled Nitric Oxide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhaled Nitric Oxide
10.3 Manufacturing Process Analysis of Inhaled Nitric Oxide
10.4 Industry Chain Structure of Inhaled Nitric Oxide

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Inhaled Nitric Oxide Distributors
11.3 Inhaled Nitric Oxide Customer

12 WORLD FORECAST REVIEW FOR INHALED NITRIC OXIDE BY GEOGRAPHIC REGION

12.1 Global Inhaled Nitric Oxide Market Size Forecast by Region
  12.1.1 Global Inhaled Nitric Oxide Forecast by Region (2026-2031)
  12.1.2 Global Inhaled Nitric Oxide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Inhaled Nitric Oxide Forecast by Type (2026-2031)
12.7 Global Inhaled Nitric Oxide Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Mallinckrodt
  13.1.1 Mallinckrodt Company Information
  13.1.2 Mallinckrodt Inhaled Nitric Oxide Product Portfolios and Specifications
  13.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Mallinckrodt Main Business Overview
  13.1.5 Mallinckrodt Latest Developments
13.2 Praxair (Linde plc)
  13.2.1 Praxair (Linde plc) Company Information
  13.2.2 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolios and Specifications
  13.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Praxair (Linde plc) Main Business Overview
  13.2.5 Praxair (Linde plc) Latest Developments
13.3 Air Liquide
  13.3.1 Air Liquide Company Information
  13.3.2 Air Liquide Inhaled Nitric Oxide Product Portfolios and Specifications
  13.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Air Liquide Main Business Overview
  13.3.5 Air Liquide Latest Developments
13.4 BOC Healthcare (Linde Group)
  13.4.1 BOC Healthcare (Linde Group) Company Information
  13.4.2 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolios and Specifications
  13.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 BOC Healthcare (Linde Group) Main Business Overview
  13.4.5 BOC Healthcare (Linde Group) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Inhaled Nitric Oxide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Inhaled Nitric Oxide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 800 ppm
Table 4. Major Players of 100 ppm
Table 5. Major Players of Others
Table 6. Global Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 7. Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Table 8. Global Inhaled Nitric Oxide Revenue by Type (2020-2025) & ($ million)
Table 9. Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2025)
Table 10. Global Inhaled Nitric Oxide Sale Price by Type (2020-2025) & (US$/L)
Table 11. Global Inhaled Nitric Oxide Sale by Application (2020-2025) & (M L)
Table 12. Global Inhaled Nitric Oxide Sale Market Share by Application (2020-2025)
Table 13. Global Inhaled Nitric Oxide Revenue by Application (2020-2025) & ($ million)
Table 14. Global Inhaled Nitric Oxide Revenue Market Share by Application (2020-2025)
Table 15. Global Inhaled Nitric Oxide Sale Price by Application (2020-2025) & (US$/L)
Table 16. Global Inhaled Nitric Oxide Sales by Company (2020-2025) & (M L)
Table 17. Global Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
Table 18. Global Inhaled Nitric Oxide Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
Table 20. Global Inhaled Nitric Oxide Sale Price by Company (2020-2025) & (US$/L)
Table 21. Key Manufacturers Inhaled Nitric Oxide Producing Area Distribution and Sales Area
Table 22. Players Inhaled Nitric Oxide Products Offered
Table 23. Inhaled Nitric Oxide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Inhaled Nitric Oxide Sales by Geographic Region (2020-2025) & (M L)
Table 27. Global Inhaled Nitric Oxide Sales Market Share Geographic Region (2020-2025)
Table 28. Global Inhaled Nitric Oxide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Inhaled Nitric Oxide Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Inhaled Nitric Oxide Sales by Country/Region (2020-2025) & (M L)
Table 31. Global Inhaled Nitric Oxide Sales Market Share by Country/Region (2020-2025)
Table 32. Global Inhaled Nitric Oxide Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Inhaled Nitric Oxide Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 35. Americas Inhaled Nitric Oxide Sales Market Share by Country (2020-2025)
Table 36. Americas Inhaled Nitric Oxide Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 38. Americas Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 39. APAC Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 40. APAC Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
Table 41. APAC Inhaled Nitric Oxide Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 43. APAC Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 44. Europe Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 45. Europe Inhaled Nitric Oxide Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 47. Europe Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 48. Middle East & Africa Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 49. Middle East & Africa Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 51. Middle East & Africa Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 52. Key Market Drivers & Growth Opportunities of Inhaled Nitric Oxide
Table 53. Key Market Challenges & Risks of Inhaled Nitric Oxide
Table 54. Key Industry Trends of Inhaled Nitric Oxide
Table 55. Inhaled Nitric Oxide Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Inhaled Nitric Oxide Distributors List
Table 58. Inhaled Nitric Oxide Customer List
Table 59. Global Inhaled Nitric Oxide Sales Forecast by Region (2026-2031) & (M L)
Table 60. Global Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Inhaled Nitric Oxide Sales Forecast by Country (2026-2031) & (M L)
Table 62. Americas Inhaled Nitric Oxide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Inhaled Nitric Oxide Sales Forecast by Region (2026-2031) & (M L)
Table 64. APAC Inhaled Nitric Oxide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Inhaled Nitric Oxide Sales Forecast by Country (2026-2031) & (M L)
Table 66. Europe Inhaled Nitric Oxide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Inhaled Nitric Oxide Sales Forecast by Country (2026-2031) & (M L)
Table 68. Middle East & Africa Inhaled Nitric Oxide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Inhaled Nitric Oxide Sales Forecast by Type (2026-2031) & (M L)
Table 70. Global Inhaled Nitric Oxide Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Inhaled Nitric Oxide Sales Forecast by Application (2026-2031) & (M L)
Table 72. Global Inhaled Nitric Oxide Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Mallinckrodt Basic Information, Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
Table 74. Mallinckrodt Inhaled Nitric Oxide Product Portfolios and Specifications
Table 75. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 76. Mallinckrodt Main Business
Table 77. Mallinckrodt Latest Developments
Table 78. Praxair (Linde plc) Basic Information, Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
Table 79. Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolios and Specifications
Table 80. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 81. Praxair (Linde plc) Main Business
Table 82. Praxair (Linde plc) Latest Developments
Table 83. Air Liquide Basic Information, Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
Table 84. Air Liquide Inhaled Nitric Oxide Product Portfolios and Specifications
Table 85. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 86. Air Liquide Main Business
Table 87. Air Liquide Latest Developments
Table 88. BOC Healthcare (Linde Group) Basic Information, Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
Table 89. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolios and Specifications
Table 90. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 91. BOC Healthcare (Linde Group) Main Business
Table 92. BOC Healthcare (Linde Group) Latest Developments



LIST OF FIGURES

Figure 1. Picture of Inhaled Nitric Oxide
Figure 2. Inhaled Nitric Oxide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhaled Nitric Oxide Sales Growth Rate 2020-2031 (M L)
Figure 7. Global Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Inhaled Nitric Oxide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Inhaled Nitric Oxide Sales Market Share by Country/Region (2024)
Figure 10. Inhaled Nitric Oxide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 800 ppm
Figure 12. Product Picture of 100 ppm
Figure 13. Product Picture of Others
Figure 14. Global Inhaled Nitric Oxide Sales Market Share by Type in 2025
Figure 15. Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2025)
Figure 16. Inhaled Nitric Oxide Consumed in Near-term and Pre-term Infants PPHN
Figure 17. Global Inhaled Nitric Oxide Market: Near-term and Pre-term Infants PPHN (2020-2025) & (M L)
Figure 18. Inhaled Nitric Oxide Consumed in Children and Adult ARDS
Figure 19. Global Inhaled Nitric Oxide Market: Children and Adult ARDS (2020-2025) & (M L)
Figure 20. Inhaled Nitric Oxide Consumed in Other Diseases
Figure 21. Global Inhaled Nitric Oxide Market: Other Diseases (2020-2025) & (M L)
Figure 22. Global Inhaled Nitric Oxide Sale Market Share by Application (2024)
Figure 23. Global Inhaled Nitric Oxide Revenue Market Share by Application in 2025
Figure 24. Inhaled Nitric Oxide Sales by Company in 2025 (M L)
Figure 25. Global Inhaled Nitric Oxide Sales Market Share by Company in 2025
Figure 26. Inhaled Nitric Oxide Revenue by Company in 2025 ($ millions)
Figure 27. Global Inhaled Nitric Oxide Revenue Market Share by Company in 2025
Figure 28. Global Inhaled Nitric Oxide Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Inhaled Nitric Oxide Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Inhaled Nitric Oxide Sales 2020-2025 (M L)
Figure 31. Americas Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
Figure 32. APAC Inhaled Nitric Oxide Sales 2020-2025 (M L)
Figure 33. APAC Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
Figure 34. Europe Inhaled Nitric Oxide Sales 2020-2025 (M L)
Figure 35. Europe Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Inhaled Nitric Oxide Sales 2020-2025 (M L)
Figure 37. Middle East & Africa Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
Figure 38. Americas Inhaled Nitric Oxide Sales Market Share by Country in 2025
Figure 39. Americas Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
Figure 40. Americas Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 41. Americas Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 42. United States Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Inhaled Nitric Oxide Sales Market Share by Region in 2025
Figure 47. APAC Inhaled Nitric Oxide Revenue Market Share by Region (2020-2025)
Figure 48. APAC Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 49. APAC Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 50. China Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 54. India Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Inhaled Nitric Oxide Sales Market Share by Country in 2025
Figure 58. Europe Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
Figure 59. Europe Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 60. Europe Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 61. Germany Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 62. France Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Inhaled Nitric Oxide Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 69. Egypt Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Inhaled Nitric Oxide in 2025
Figure 75. Manufacturing Process Analysis of Inhaled Nitric Oxide
Figure 76. Industry Chain Structure of Inhaled Nitric Oxide
Figure 77. Channels of Distribution
Figure 78. Global Inhaled Nitric Oxide Sales Market Forecast by Region (2026-2031)
Figure 79. Global Inhaled Nitric Oxide Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Inhaled Nitric Oxide Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Inhaled Nitric Oxide Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Inhaled Nitric Oxide Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Inhaled Nitric Oxide Revenue Market Share Forecast by Application (2026-2031)